This publication is a summary of the opinion “The safety of dental amalgam and alternative dental restoration materials for patients and users” produced in 2015 by the SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) of the European Commission.
Levels 1 & 2 were written by the GreenFacts editorial team and the DG Health and Consumers of the European Commission. This publication is produced by GreenFacts under a contract from the DG Health and Consumers of the European Commission.
The Committee provides opinions on emerging or newly-identified health and environmental risks and on broad, complex or multidisciplinary issues requiring a comprehensive assessment of risks to consumer safety or public health and related issues not covered by other Community risk assessment bodies.
For further information on the SCENIHR, see:
http://ec.europa.eu/health/scientific_committees/emerging/index_en.htm
Dental amalgam and its substitutes are regulated under Council Directive 93/42/EEC concerning medical devices, according to which they must comply with the essential requirements laid out in the directive, in particular in relation to the health and safety of the patients.
In January 2005, the Commission adopted a proposal for a Community Strategy concerning Mercury in order to reduce mercury levels in the environment and human exposure. Pursuant to Action 6 of the Strategy, the use of dental amalgam should be evaluated with a view to considering whether additional regulatory measures are appropriate.
In view of the above, the Commission requested the opinion of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) on the safety of dental amalgam and alternative dental restoration materials. According to the SCENIHR opinion adopted in May 2008, dental amalgam is a safe material to use in restorative dentistry for patients. No health risk other than allergic reaction in certain individuals can be associated with the use of dental amalgam. The alternatives are not without clinical limitations and toxicological risks, and less is known about these alternatives for which available scientific data are more limited.
The SCENIHR is asked the following questions:
This summary is free and ad-free, as is all of our content. You can help us remain free and independant as well as to develop new ways to communicate science by becoming a Patron!